Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - AU
The Guardian - AU
Business
Jonathan Barrett Business editor

CSL share price plummets amid shareholder revolt over executive pay plans

CSL’s headquarters in Melbourne
The biotech company is seeing shareholder unrest linked to a perceived mismatch between its performance and high executive pay, as CSL’s share price drops following its AGM. Photograph: JHVEPhoto/Alamy

The Australian biotech company CSL has been delivered a “second strike” by shareholders over its executive pay plans, but has survived a push to spill its board.

Amid frustration over its depressed share price, which fell even further on Tuesday, the blood plasma therapy firm saw more than 40% of votes cast against its executive pay plans at its annual general meeting in Melbourne on Tuesday.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.